NewEdge Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-669
| Closed | -$425K | – | 1019 |
|
|
2025
Q1 | $425K | Sell |
669
-40,096
| -98% | -$25.4M | 0.01% | 693 |
|
|
2024
Q4 | $29M | Buy |
40,765
+3,636
| +10% | +$2.59M | 0.5% | 51 |
|
|
2024
Q3 | $39M | Buy |
37,129
+858
| +2% | +$902K | 0.7% | 34 |
|
|
2024
Q2 | $38.1M | Buy |
36,271
+11
| +0% | +$11.6K | 0.83% | 28 |
|
|
2024
Q1 | $34M | Buy |
36,260
+3,541
| +11% | +$3.32M | 0.76% | 29 |
|
|
2023
Q4 | $28.7M | Buy |
32,719
+4,287
| +15% | +$3.77M | 0.73% | 32 |
|
|
2023
Q3 | $23.4M | Buy |
28,432
+7,099
| +33% | +$5.84M | 0.74% | 33 |
|
|
2023
Q2 | $15.3M | Buy |
21,333
+737
| +4% | +$530K | 0.51% | 54 |
|
|
2023
Q1 | $16.9M | Buy |
20,596
+983
| +5% | +$808K | 0.64% | 43 |
|
|
2022
Q4 | $14.2M | Buy |
19,613
+875
| +5% | +$631K | 0.61% | 46 |
|
|
2022
Q3 | $12.9M | Buy |
18,738
+1,864
| +11% | +$1.28M | 0.61% | 48 |
|
|
2022
Q2 | $9.98M | Buy |
16,874
+571
| +4% | +$338K | 0.45% | 59 |
|
|
2022
Q1 | $11.4M | Buy |
16,303
+6,989
| +75% | +$4.88M | 0.51% | 48 |
|
|
2021
Q4 | $5.88M | Buy |
+9,314
| New | +$5.88M | 0.25% | 101 |
|
|
2021
Q2 | – | Sell |
-1,188
| Closed | -$562K | – | 306 |
|
|
2021
Q1 | $562K | Buy |
+1,188
| New | +$562K | 0.06% | 209 |
|